Page last updated: 2024-08-26

bosentan anhydrous and Carcinoma

bosentan anhydrous has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogaard, HJ; Botros, L; Van Nieuw Amerongen, GP; Vonk Noordegraaf, A1
Brock, P; Emmrich, J; Fitzner, B; Holzhüter, SA; Jaster, R; Liebe, S; Nizze, H; Sparmann, G1

Other Studies

2 other study(ies) available for bosentan anhydrous and Carcinoma

ArticleYear
Recovery from mitomycin-induced pulmonary arterial hypertension.
    Annals of the American Thoracic Society, 2014, Volume: 11, Issue:3

    Topics: Antineoplastic Agents; Anus Neoplasms; Bosentan; Carcinoma; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Middle Aged; Mitomycin; Sulfonamides

2014
Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells.
    Digestive diseases and sciences, 2009, Volume: 54, Issue:2

    Topics: Animals; Bosentan; Carcinoma; Cell Line, Tumor; Coculture Techniques; Collagen; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Organotin Compounds; Pancreas; Pancreatic Neoplasms; Pancreatitis, Chronic; Rats; Receptors, Endothelin; Sulfonamides

2009